These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 412107)

  • 1. Hapten-induced allosteric transition in the light chain dimer of an immunoglobulin.
    Lancet D; Licht A; Schechter I; Pecht I
    Nature; 1977 Oct; 269(5631):827-9. PubMed ID: 412107
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetic evidence for hapten-induced conformational transition in immunoglobin MOPC 460.
    Lancet D; Pecht I
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3549-53. PubMed ID: 1068466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interchain disulfide bond on hapten binding properties of light chain dimer of protein 315.
    Zidovetski R; Licht A; Pecht I
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5848-52. PubMed ID: 118454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive cooperativity in the hapten binding by the VL dimer of protein 315.
    Zidovetzki R; Licht A; Pecht I
    Mol Immunol; 1981 Jun; 18(6):491-7. PubMed ID: 6796824
    [No Abstract]   [Full Text] [Related]  

  • 5. Resonance Raman-spectroscopic studies of the hapten features involved in the binding of 2,4-dinitrophenyl haptens by the mouse myeloma proteins MOPC 315 and MOPC 460.
    Kumar K; Phelps DJ; Carey PR; Young NM
    Biochem J; 1978 Nov; 175(2):727-35. PubMed ID: 743221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the fine specificity of anti-dinitrophenyl-combining site composed of either VL dimer or VL and VH of protein 315.
    Gavish M; Dwek RA; Givol D
    Biochemistry; 1977 Jul; 16(14):3154-9. PubMed ID: 70219
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-V region framework antibodies affect the ligand binding of VL dimer.
    Ben-Neriah Y; Givol D; Gavish M
    Eur J Immunol; 1979 Jan; 9(1):91-3. PubMed ID: 108113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular dichroism of hapten-antibody complexes: studies of tryptophanyl residue involvement in the antibody combining sites of MOPC-315 protein heavy and light chain subunits, reconstituted MOPC-315 protein and its FV-fragment.
    Freed RM; Rockey JH; Davis RC
    Immunochemistry; 1976 Jun; 13(6):509-15. PubMed ID: 820635
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural studies in solution on the combining site of the myeloma protein MOPC 315.
    Dwek RA
    Contemp Top Mol Immunol; 1977; 6():1-52. PubMed ID: 232031
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity of interactions of hapten side chains with the combining site of the myeloma protein MOPC 315.
    Wain-Hobson S; Dower SK; Gettins P; Givol D; McLaughlin AC; Pecht I; Sunderland CA; Dwek RA
    Biochem J; 1977 Aug; 165(2):227-35. PubMed ID: 921746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison by 1H NMR of the hapten environment in the combining site of the dinitrophenyl binding IgA protein 315 and its fragments.
    Morris AT; Givol D; Dwek RA
    Immunochemistry; 1978 Aug; 15(8):519-22. PubMed ID: 730222
    [No Abstract]   [Full Text] [Related]  

  • 12. The distance between the contact sites for DNP and menadione ligands in the combining region of myeloma proteins binding both haptens--I. Estimation of distance by fluorescent energy transfer in protein 460.
    Manjula BN; Richards FF; Rosenstein RW
    Immunochemistry; 1976 Nov; 13(11):929-37. PubMed ID: 1010601
    [No Abstract]   [Full Text] [Related]  

  • 13. The distance between the contact sites for DNP and menadione ligands in the combining region of myeloma proteins binding both haptens--II. Estimation of distance using haptenic probes with variable length spacers.
    Rosenstein RW; Richards FF
    Immunochemistry; 1976 Nov; 13(11):939-43. PubMed ID: 1010602
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigen-binding myeloma proteins of mice.
    Potter M
    Adv Immunol; 1977; 25():141-211. PubMed ID: 76433
    [No Abstract]   [Full Text] [Related]  

  • 15. Arginine as a contact residue in the hapten-binding site of protein 315.
    Klostergaard J; Krausz LM; Grossberg AL; Pressman D
    Immunochemistry; 1977 Feb; 14(2):107-10. PubMed ID: 852884
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the dimensions of the combining sites of the dinitrophenyl-binding immunoglobulin A myeloma proteins MOPC 315, MOPC 460 and XRPC 25 by spin-label mapping.
    Willan KJ; Marsh D; Sunderland CA; Sutton BJ; Wain-Hobson S; Dwek RA; Givol D
    Biochem J; 1977 Aug; 165(2):199-206. PubMed ID: 200220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic evidence for a conformational change by an anti-hapten antibody upon binding multivalent hapten.
    Barisas BG; Singer SJ; Sturtevant JM
    Immunochemistry; 1977 Apr; 14(4):247-52. PubMed ID: 873566
    [No Abstract]   [Full Text] [Related]  

  • 18. Parallel expression of new idiotypes on T and B cells.
    Julius MH; Cosenza H; Augustin AA
    Nature; 1977 Jun; 267(5610):437-9. PubMed ID: 69272
    [No Abstract]   [Full Text] [Related]  

  • 19. Contributions of immunoglobulin heavy and light chains to antibody specificity for lysozyme and two haptens.
    Smith-Gill SJ; Hamel PA; Lovoie TB; Dorrington KJ
    J Immunol; 1987 Dec; 139(12):4135-44. PubMed ID: 2447160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of an antibody combining site by magnetic resonance.
    Dwek RA; Wain-Hobson S; Dower S; Gettins P; Sutton B; Perkins SJ; Givol D
    Nature; 1977 Mar; 266(5597):31-7. PubMed ID: 190543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.